Cargando…
Neuromyelitis optica spectrum disorders: from pathophysiology to therapeutic strategies
Neuromyelitis optica (NMO) is a chronic inflammatory autoimmune disease of the central nervous system (CNS) characterized by acute optic neuritis (ON) and transverse myelitis (TM). NMO is caused by a pathogenic serum IgG antibody against the water channel aquoporin 4 (AQP4) in the majority of patien...
Autores principales: | Carnero Contentti, Edgar, Correale, Jorge |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8444436/ https://www.ncbi.nlm.nih.gov/pubmed/34530847 http://dx.doi.org/10.1186/s12974-021-02249-1 |
Ejemplares similares
-
Immunosuppression during the COVID-19 pandemic in neuromyelitis optica spectrum disorders patients: A new challenge
por: Carnero Contentti, Edgar, et al.
Publicado: (2020) -
Interleukin-6 in neuromyelitis optica spectrum disorder pathophysiology
por: Fujihara, Kazuo, et al.
Publicado: (2020) -
Treatment of neuromyelitis optica/neuromyelitis optica spectrum disorders with methotrexate
por: Ramanathan, Ramnath Santosh, et al.
Publicado: (2014) -
Treatment of Neuromyelitis Optica Spectrum Disorders
por: Chan, Koon-Ho, et al.
Publicado: (2021) -
Neuromyelitis optica spectrum disorders: An update
por: Pandit, Lekha
Publicado: (2015)